Volume 12 Issue 6
Nov.  2021
Turn off MathJax
Article Contents
Article Navigation >  ORGAN TRANSPLANTATION  > 2021  >  12(6): 720-726
Huang Heyu, Sun Xiaodong, Chen Yuguo, et al. Multi-disciplinary team of complex cholestatic liver injury after liver transplantation[J]. ORGAN TRANSPLANTATION, 2021, 12(6): 720-726. doi: 10.3969/j.issn.1674-7445.2021.06.012
Citation: Huang Heyu, Sun Xiaodong, Chen Yuguo, et al. Multi-disciplinary team of complex cholestatic liver injury after liver transplantation[J]. ORGAN TRANSPLANTATION, 2021, 12(6): 720-726. doi: 10.3969/j.issn.1674-7445.2021.06.012
shu

Multi-disciplinary team of complex cholestatic liver injury after liver transplantation

doi: 10.3969/j.issn.1674-7445.2021.06.012

  • Liver Transplantation Center, the First Hospital of Jilin University, Changchun 130000, China

More Information
  • Corresponding author: Lyu Guoyue, Email: lgy08@sina.com
  • Received Date: 2021-08-05
  • Publish Date: 2021-11-15
    Abstract
  •   Objective  To investigate the role of multi-disciplinary team (MDT) in the treatment of complex cholestatic liver injury after liver transplantation.  Methods  MDT consultation was conducted to clarify the causes and therapeutic strategies for one case of complex cholestatic liver injury after liver transplantation admitted to Liver Transplantation Center of the First Hospital of Jilin University on June 23, 2020. And the role of MDT in the treatment of complex cholestatic liver injury after liver transplantation was summarized.  Results  The patient presented with abnormal liver function after liver transplantation. The diagnosis of biliary stricture, rejection and biliary tract infection was confirmed successively. Endoscopic retrograde cholangiopancreatography (ERCP) stent internal and external double drainage, glucocorticoid shock and anti-infection therapy yielded low clinical efficacy. After MDT consultation, complex cholestatic liver injury after liver transplantation was confirmed. It was suggested to optimize the immunosuppressive regimen based on the exclusion of rejections by pathological examination, deliver targeted anti-infection interventions and prevent the potential risk of concomitant drug-induced liver injury. The patient was discharged after proper recovery.  Conclusions  The causes of complex cholestatic liver injury after liver transplantation are diverse, and the condition changes dynamically. MDT consultation are performed to deepen the understanding of this disease, strengthen the classification of diagnosis and treatment ideas and enhance the precision and efficacy of corresponding treatment.

     

    • FullText(HTML)
  • loading
    • References(27)
  • [1]
    DAR WA, SULLIVAN E, BYNON JS, et al. Ischaemia reperfusion injury in liver transplantation: cellular and molecular mechanisms[J]. Liver Int, 2019, 39(5): 788-801. DOI: 10.1111/liv.14091.
    [2]
    胡利琳, 王玮珺, 杨玲. 肝细胞型胆汁淤积诊治进展[J]. 实用肝脏病杂志, 2020, 23(1): 后插4-后插8. DOI: 10.3969/j.issn.1672-5069.2020.01.043.

    HU LL, WANG WJ, YANG L. Diagnosis and treatment ofparenchymal jaundice: a type of cholestasis[J]. J Pract Hepatol, 2020, 23(1): back insert 4- back insert 8. DOI: 10.3969/j.issn.1672-5069.2020.01.043.
    [3]
    申弘, 胡萌, 魏泽辉, 等. 胆汁的生成、分泌、排泄及胆汁淤积发生机制[J]. 临床肝胆病杂志, 2019, 35(2): 431-437. DOI: 10.3969/j.issn.1001-5256.2019.02.043.

    SHEN H, HU M, WEI ZH, et al. Bile formation, secretion, and excretion and the pathogenesis of cholestasis[J]. J Clin Hepatol, 2019, 35(2): 431-437. DOI: 10.3969/j.issn.1001-5256.2019.02.043.
    [4]
    YOKODA RT, RODRIGUEZ EA. Review: pathogenesis of cholestatic liver diseases[J]. World J Hepatol, 2020, 12(8): 423-435. DOI: 10.4254/wjh.v12.i8.423.
    [5]
    HEATHCOTE EJ. Diagnosis and management of cholestatic liver disease[J]. Clin Gastroenterol Hepatol, 2007, 5(7): 776-782. DOI: 10.1016/j.cgh.2007.05.008.
    [6]
    European Association for the Study of the Liver. EASL clinical practice guidelines: management of cholestatic liver diseases[J]. J Hepatol, 2009, 51(2): 237-267. DOI: 10.1016/j.jhep.2009.04.009.
    [7]
    中华医学会肝病学分会, 中华医学会消化病学分会, 中华医学会感染病学分会. 胆汁淤积性肝病诊断和治疗共识(2015)[J]. 实用肝脏病杂志, 2016, 19(6): 771-781. DOI: 10.3969/j.issn.1672-5069.2016.06.040.

    Branch of Hepatology of Chinese Medical Association, Branch of Gastroenterology of Chinese Medical Association, Branch of Infectious Diseases of Chinese Medical Association. Consensus on the diagnosis and treatment of cholestasis liver diseases (2015)[J]. J Pract Hepatol, 2016, 19(6): 771-781. DOI: 10.3969/j.issn.1672-5069.2016.06.040.
    [8]
    陈虹, 王旭, 张庆, 等. 肝移植术后中远期黄疸的原因分析与治疗[J]. 中华器官移植杂志, 2012, 33(2): 97-100. DOI: 10.3760/cma.j.issn.0254-1785.2012.02.008.

    CHEN H, WANG X, ZHANG Q, et al. Etiological analysis and treatment of jaundice after liver transplantation during mid-later stage[J]. Chin J Organ Transplant, 2012, 33(2): 97-100. DOI: 10.3760/cma.j.issn.0254-1785.2012.02.008.
    [9]
    赵川, 陈虹, 范铁艳, 等. 成人肝移植术后中远期胆汁淤积性肝病的研究现状[J]. 中华灾害救援医学, 2016, 4(3): 170-173. DOI: 10.13919/j.issn.2095-6274.2016.03.014.

    ZHAO C, CHEN H, FAN TY, et al. Research status of medium and long term cholestatic liver disease after liver transplantation in adults[J]. Chin J Disaster Med, 2016, 4(3): 170-173. DOI: 10.13919/j.issn.2095-6274.2016.03.014.
    [10]
    LO RC, CHAN KK, CHOK KS, et al. Liver allograft biopsies with histological cholestasis: a clinicopathological study of 254 cases from a single centre[J]. J Clin Pathol, 2018, 71(1): 72-78. DOI: 10.1136/jclinpath-2017-204334.
    [11]
    DE VRIES Y, VON MEIJENFELDT FA, PORTE RJ. Post-transplant cholangiopathy: classification, pathogenesis, and preventive strategies[J]. Biochim Biophys Acta Mol Basis Dis, 2018, 1864(4 Pt B): 1507-1515. DOI: 10.1016/j.bbadis.2017.06.013.
    [12]
    ANGELICO R, GERLACH UA, GUNSON BK, et al. Severe unresolved cholestasis due to unknown etiology leading to early allograft failure within the first 3 months of liver transplantation[J]. Transplantation, 2018, 102(8): 1307-1315. DOI: 10.1097/TP.0000000000002139.
    [13]
    DEMETRIS AJ, BELLAMY C, HÜBSCHER SG, et al. 2016 comprehensive update of the Banff Working Group on liver allograft pathology: introduction of antibody-mediated rejection[J]. Am J Transplant, 2016, 16(10): 2816-2835. DOI: 10.1111/ajt.13909.
    [14]
    MONTANO-LOZA AJ, BHANJI RA, WASILENKO S, et al. Systematic review: recurrent autoimmune liver diseases after liver transplantation[J]. Aliment Pharmacol Ther, 2017, 45(4): 485-500. DOI: 10.1111/apt.13894.
    [15]
    MONTANO-LOZA AJ, HANSEN BE, CORPECHOT C, et al. Factors associated with recurrence of primary biliary cholangitis after liver transplantation and effects on graft and patient survival[J]. Gastroenterology, 2019, 156(1): 96-107. DOI: 10.1053/j.gastro.2018.10.001.
    [16]
    HILDEBRAND T, PANNICKE N, DECHENE A, et al. Biliary strictures and recurrence after liver transplantation for primary sclerosing cholangitis: a retrospective multicenter analysis[J]. Liver Transpl, 2016, 22(1): 42-52. DOI: 10.1002/lt.24350.
    [17]
    NEVENS F. PBC-transplantation and disease recurrence[J]. Best Pract Res Clin Gastroenterol, 2018, 34/35: 107-111. DOI: 10.1016/j.bpg.2018.09.001.
    [18]
    TRONINA O, ŚLUBOWSKA K, MIKOŁAJCZYK-KORNIAK N, et al. Fibrosing cholestatic hepatitis C after liver transplantation: therapeutic options before and after introduction of direct-acting antivirals: our experience and literature review[J]. Transplant Proc, 2017, 49(6): 1409-1418. DOI: 10.1016/j.transproceed.2017.01.077.
    [19]
    LLOVET LP, SCIARRONE S, RODRÍGUEZ-TAJES S, et al. Ductular reaction and hepatocyte ballooning identify patients with fibrosing cholestatic hepatitits after liver transplantation[J]. Gastroenterol Hepatol, 2020, 43(1): 14-21. DOI: 10.1016/j.gastrohep.2019.07.006.
    [20]
    SEMBERA S, LAMMERT C, TALWALKAR JA, et al. Frequency, clinical presentation, and outcomes of drug-induced liver injury after liver transplantation[J]. Liver Transpl, 2012, 18(7): 803-810. DOI: 10.1002/lt.23424.
    [21]
    GONZÁLEZ-DIÉGUEZ ML, VISO VIDAL D, MENDOZA PACAS GE, et al. Tacrolimus-induced cholestatic hepatitis in a patient with liver transplant[J]. Transplantation, 2018, 102(10): e454-e456. DOI: 10.1097/TP.0000000000002332.
    [22]
    VÉLEZ-GONZÁLEZ F, BALLESTER V, ANTÚNEZ I, et al. Rejection, recurrence, or something else?[J]. Bol Asoc Med P R, 2016, 108(2): 39-41.
    [23]
    KOHLI DR, DESAI MV, KENNEDY KF, et al. Patients with post-transplant biliary strictures have significantly higher rates of liver transplant failure and rejection: a nationwide inpatient analysis[J]. J Gastroenterol Hepatol, 2021, 36(7): 2008-2014. DOI: 10.1111/jgh.15388.
    [24]
    蔡云石, 刘雄威, 肖衡, 等. 肝移植术后胆道并发症的诊治[J/CD]. 中华肝脏外科手术学电子杂志, 2018, 7(5): 391-395. DOI: 10.3877/cma.j.issn.2095-3232.2018.05.011.

    CAI YS, LIU XW, XIAO H, et al. Biliary complications after liver transplantation: diagnosis and treatments[J/CD]. Chin J Hepatic Surg (Electr Edit), 2018, 7(5): 391-395. DOI: 10.3877/cma.j.issn.2095-3232.2018.05.011.
    [25]
    LARGHI A, TRINGALI A, RIMBAŞ M, et al. Endoscopic management of benign biliary strictures after liver transplantation[J]. Liver Transpl, 2019, 25(2): 323-335. DOI: 10.1002/lt.25358.
    [26]
    中华医学会器官移植学分会. 中国肝移植免疫抑制治疗与排斥反应诊疗规范(2019版)[J]. 器官移植, 2021, 12(1): 8-14, 28. DOI: 10.3969/j.issn.1674-7445.2021.01.002.

    Branch of Organ Transplantation of Chinese Medical Association. Diagnosis and treatment specification for immunosuppressive therapy and rejection of liver transplantation in China (2019 edition)[J] Organ Transplant, 2021, 12(1): 8-14, 28. DOI: 10.3969/j.issn.1674-7445.2021.01.002.
    [27]
    杨雪, 涂荣芳, 杨晋辉. 药物性肝损伤的研究进展[J]. 临床肝胆病杂志, 2020, 36(3): 509-513. DOI: 10.3969/j.issn.1001-5256.2020.03.006.

    YANG X, TU RF, YANG JH. Research advances in drug-induced liver injury[J]. J Clin Hepatol, 2020, 36(3): 509-513. DOI: 10.3969/j.issn.1001-5256.2020.03.006.
    • Relative Articles
    • Supplements(0)
    • Cited By
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Figures(4)  / Tables(1)

    Get Citation
    PDF
    XML

    Article Metrics

    Article views (348) PDF downloads(80) Cited by()
    Proportional views
    Related

    WeChat Subscription Account

    Wechat Service Account

    Contact Us
    • Tel：020-38736410
    • Email: organtranspl@163.com
    • Address：The Third Affiliated Hospital of Sun Yat-sen University, No. 600, Tianhe Road, Tianhe District, Guangzhou
    • Editorial Office of Organ Transplantation  粤ICP备2021030844号
    Links

    Supported by: Beijing Renhe Information Technology Co. Ltd    

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return